Cerus Corp CERS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/18/22 EDT
4.78UNCH (UNCH)
Volume
1,694,068
Close
4.78quote price arrow down-0.34 (-6.64%)
Volume
2,687,581
52 week range
4.38 - 8.05
Loading...
  • Open5.01
  • Day High5.06
  • Day Low4.76
  • Prev Close4.78
  • 52 Week High8.05
  • 52 Week High Date11/05/21
  • 52 Week Low4.38
  • 52 Week Low Date04/22/22

Key Stats

  • Market Cap845.58M
  • Shares Out176.90M
  • 10 Day Average Volume3.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-29.81

KEY STATS

  • Open5.01
  • Day High5.06
  • Day Low4.76
  • Prev Close4.78
  • 52 Week High8.05
  • 52 Week High Date11/05/21
  • 52 Week Low4.38
  • 52 Week Low Date04/22/22
  • Market Cap845.58M
  • Shares Out176.90M
  • 10 Day Average Volume3.52M
  • Dividend-
  • Dividend Yield-
  • Beta1.20
  • YTD % Change-29.81

RATIOS/PROFITABILITY

  • EPS (TTM)-0.29
  • P/E (TTM)-16.77
  • Fwd P/E (NTM)-16.48
  • EBITDA (TTM)-39.118M
  • ROE (TTM)-57.19%
  • Revenue (TTM)172.97M
  • Gross Margin (TTM)59.27%
  • Net Margin (TTM)-28.45%
  • Debt To Equity (MRQ)87.87%

EVENTS

  • Earnings Date08/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cerus Corp

There is no recent news for this security.

Profile

MORE
Cerus Corporation is a biomedical products company. It is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, which is based on its technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives, such as plasma, platelets...
Daniel Swisher Jr.
Independent Chairman of the Board
William Greenman
President, Chief Executive Officer, Director
Vivek Jayaraman
Chief Operating Officer
Kevin Green CPA
Chief Financial Officer, Vice President - Finance
Chrystal Menard J.D.
Chief Legal Officer, General Counsel
Address
1220 Concord Ave Ste 600
Concord, CA
94520-4906
United States

Top Peers

SYMBOLLASTCHG%CHG
ANIK
Anika Therapeutics Inc
21.90-0.65-2.88%
UFPT
UFP Technologies Inc
74.70-4.90-6.16%
SRDX
Surmodics Inc
37.00-2.01-5.15%
ANGO
AngioDynamics Inc
19.46-0.82-4.04%
VIVO
Meridian Bioscience Inc
25.29-0.08-0.32%